Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cogentix Medical
Minnetonka, Minnesota, United States
- Ownership
- Private
- Employees
- ~51
- Development stage
- Other
01
Overview
Cogentix Medical developed commercialized medical devices for urology, particularly for the treatment of overactive bladder (OAB) and female stress urinary incontinence (SUI); main products included the Urgent PC Neuromodulation System (for PTNS treatment of OAB), Macroplastique (injectable bulking agent for SUI), and PrimeSight (flexible endoscopy with disposable barrier technology). Their products were FDA-cleared and in active use before acquisition[1][2][3][4].
- Therapeutic areas
- UrologyWomen's HealthNephrologyOther
- Modalities
- DeviceInjectable implantNeuromodulation device
- Industry
- Therapeutic Medical Devices
Beyond the preview
Go deeper on Cogentix Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cogentix Medical.